Journal
JOURNAL OF CLINICAL PATHOLOGY
Volume 76, Issue 8, Pages 566-570Publisher
BMJ PUBLISHING GROUP
DOI: 10.1136/jcp-2023-208901
Keywords
ETHICS; EPIDEMIOLOGY; Health Services
Categories
Ask authors/readers for more resources
This study examined the financial relationships between pathologists and the healthcare industry in the USA from 2013 to 2021. The findings showed that 49.5% of pathologists received payments totaling $356.7 million, with 68.2% of these payments being for research. Male pathologists specializing in blood banking and transfusion medicine and hematopathology were more likely to receive both research and non-research payments.
Although proper physician-industry financial relationships are essential for improving patient care, they can also cause potential conflicts of interest. However, little is known about the pathologist-industry financial relationships. Using the 2013-2021 Open Payments Database, this cross-sectional study investigated both research and non-research payments to all pathologists in the USA. Payment data were analyzed descriptively. Of 21,664 pathologists, 49.5% of all pathologists have received payments totaling $356.7 million from the healthcare industry, of which 68.2% were research payments. Median per-physician general and associated research payments (IQR) were $145($49-$575) and $70,926 ($17,450-$299,285) over the nine years. The top 1% of pathologists receiving general payments received 68.0% of all general payments. Male pathologists specializing in blood banking and transfusion medicine and hematopathology are significantly more likely than those not to receive research and non-research payments. This first study provides valuable insights into the financial relationships between pathologists and the healthcare industry.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available